Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 51.59

-1.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	1/8/2004 7:22:06 AM
From: nigel bates	of 52153

Today's 'glass half full' moment - ImmunoGen, Inc. to Advance its Lead Product Candidates Cantuzumab Mertansine and huN901-DM1 into its Own Proof-of-Concept Studies ImmunoGen loses 2 partners in cancer drugs Which is the company PR, and which the Reuters headline...? Message 19667070

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next